ArticleInfectious medicine2025
Estimated incidence of influenza in Guangzhou, China, 2019-2022.
Article in Infectious medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Influenza is a significant public health issue, particularly for vulnerable groups like children and the elderly. Despite widespread vaccination and public health measures, age-specific incidence data-crucial for targeted interventions-are limited in many areas, including Guangzhou. The epidemiological patterns of influenza have also been affected by non-pharmaceutical interventions during the COVID-19 pandemic, underscoring the need for updated local estimates. This study aimed to estimate the age-specific incidence of influenza infection in Guangzhou from 2019 to 2022-a period covering both pre-pandemic and pandemic phases-to inform regionally tailored prevention and control strategies. Methods: This study analyzed surveillance data on influenza-like illness (ILI) and virological test results from sentinel hospitals in Guangzhou covering the period from 2019 to 2022. A previously established multiplier model was employed, which integrated age-specific consultation rates, influenza positivity rates, as well as parameters related to symptom presentation and detection sensitivity. Monte Carlo simulations were utilized to estimate annual age-stratified influenza infection and incidence rates, accompanied by 95% confidence intervals. The population denominators were derived from the national census conducted in 2020. Results: 7.78% of the total population in Guangzhou were infected by influenza in 2019, 1.40% in 2020, 1.85% in 2021 and 12.13% in 2022 and incidence rates were 5.15% in 2019, 0.93% in 2020, 1.23% in 2021 and 8.04% in 2022. The highest influenza infection and incidence rates were observed in 2022 and the lowest in 2020. Infections in the 0-14 age group were 27.19%, 3.57%, 11.16% and 66.15% during 2019-2022 and respective incidence rates were 18.00%, 2.37%, 7.41% and 43.84%. Conclusions: 0-14-year-old infants and children were the main victims of influenza. Targeted strategies should be developed to prevent the spread in this age group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.